Inhaled drug delivery: Mechanisms by which pressurised metered dose inhaler excipients affect respiratory membrane biophysics.
吸入药物输送:加压定量吸入器赋形剂影响呼吸膜生物物理学的机制。
基本信息
- 批准号:1764834
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:英国
- 项目类别:Studentship
- 财政年份:2016
- 资助国家:英国
- 起止时间:2016 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Strategi Research Priority: Bioscience for HealthBackground: Glycerol was added to some products as a non-volatile component to modify aerosol particle size when pressurised metered dose inhalers were reformulated with hydrofluoroalkanes in the 1990's to comply with the Montreal treaty on greenhouse gases. It was recently discovered that the addition of glycerol to inhaler formulations to increase aerosol particle size may affect drug bioavailability even when pharmaceutical aerosols are aerodynamically equivalent. Previous studies comparing glycerol free and glycerol containing formulations have observed differences in the pharmaceutical properties and performances of these formulations. It is hypothesized that the effects of glycerol on the disposition of deposited drug goes beyond changes in particle size. Not only may glycerol have effects on the release of drug from the aerosol particle, it might also play a role in transiently modifying the permeability of the lung cell membranes. The aim of this study is to gain more insight into the effect glycerol present in inhaled drug particles would have on the permeability of the airway epithelium. These effects will be studied in vitro using the Calu-3 cell continuous cell line. Specific objectives include evaluation of Calu-3 cells tolerability to glycerol. The outcome of the tolerability studies will be used to establish a concentration range for further investigations into the effect of glycerol on the permeability of cell layers using transport markers in vitro.Method: The MTT assay was used to evaluate the toxicity of glycerol to the cells and to determine an LC50 value. Glycerol concentrations ranged between 1% to 35% v/v. The effect of glycerol on the cell layer integrity was investigated via trans-epithelial electrical resistance (TEER) measurements. Cell layer permeability of two transport markers; 3H-digoxin and 14C-Mannitol (transcellular and paracellular transport markers respectively) was also assessed. The glycerol concentrations chosen for the permeability studies were such that gave cell viability between 60% and 100% as reported by the MTT studies.Results: LC50 value was determined by to be 14% v/v. TEER values showed that the tight junctions were perturbed with increasing glycerol concentration and upon prolonged glycerol exposure. Permeability across cell layers for both markers was also enhanced by glycerol (24-fold for mannitol and 6-fold for digoxin). This was expected for mannitol especially because the tight junctions which constitute the paracellular route had been compromised.Conclusion: The LC50 of glycerol with Calu-3 cells was determined and the range of concentrations used in the toxicity assay showed the extent of tolerability of the cell line to glycerol. Glycerol also appeared to enhance the permeability of cell monolayers to transport markers. Further studies are required to establish optimum conditions for the investigation of BDP transport and whether this observed glycerol effect on membrane permeability translates to effects on drug transport in lung tissue.
战略研究优先级:健康生物科学背景:在20世纪90年代,为了遵守蒙特利尔温室气体条约,当加压计量吸入器用氢氟烷烃重新配制时,甘油作为非挥发性组分被添加到一些产品中以改变气溶胶颗粒尺寸。最近发现,即使当药用气雾剂在气动力学上等效时,向吸入器制剂中添加甘油以增加气雾剂粒度也可能影响药物生物利用度。先前比较无甘油和含甘油制剂的研究已经观察到这些制剂的药物性质和性能的差异。据推测,甘油对沉积药物处置的影响超出了粒度变化。甘油不仅可以影响药物从气溶胶颗粒中的释放,它还可以在瞬时改变肺细胞膜的渗透性方面发挥作用。本研究的目的是更深入地了解吸入药物颗粒中存在的甘油对气道上皮细胞渗透性的影响。将使用Calu-3细胞连续细胞系在体外研究这些效应。具体目标包括评价Calu-3细胞对甘油的耐受性。的耐受性研究的结果将被用来建立一个浓度范围,用于进一步调查甘油对细胞层的渗透性使用运输markers in vitro.Method的影响:MTT法被用来评估甘油的毒性细胞,并确定LC 50值。甘油浓度范围为1%至35%v/v。甘油对细胞层完整性的影响通过跨上皮电阻(TEER)测量进行了研究。还评估了两种转运标记物的细胞层渗透性; 3 H-地高辛和14 C-甘露糖醇(分别为跨细胞和细胞旁转运标记物)。选择的渗透性研究的甘油浓度是这样的,给细胞活力在60%和100%之间的MTT study.Results报告:LC 50值确定为14%v/v。TEER值表明,随着甘油浓度的增加,并在长期甘油暴露的紧密连接被扰乱。两种标记物跨细胞层的渗透性也被甘油增强(甘露醇为24倍,地高辛为6倍)。这是预期甘露醇,特别是因为紧密连接,构成的paracellular route已compromised.Conclusion:的LC 50的甘油与Calu-3细胞的测定和毒性试验中使用的浓度范围显示的耐受性的细胞系甘油的程度。甘油似乎也能增强细胞单层对转运标记物的渗透性。需要进一步研究以确定研究BDP转运的最佳条件,以及观察到的甘油对膜通透性的影响是否转化为对肺组织中药物转运的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
-- - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
-- - 项目类别:
Studentship
相似国自然基金
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
- 批准号:82371102
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
- 批准号:82371224
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TCF7L2突变介导SMAD7信号轴抑制KRAS突变型结直肠癌转移及耐药的分子机制研究
- 批准号:32000555
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
- 批准号:31900528
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
- 批准号:61372188
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
- 批准号:81172109
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
多巴胺系统在中枢神经系统疾病发病机理作用的研究
- 批准号:31123002
- 批准年份:2011
- 资助金额:300.0 万元
- 项目类别:专项基金项目
基于siRNA文库筛选的膀胱癌生物治疗的细胞和分子机制研究
- 批准号:81172419
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Electrochemically Generated Inhaled Nitric Oxide (iNO) delivery via High Flow Nasal Cannula (HFNC)
通过高流量鼻插管 (HFNC) 输送电化学产生的吸入一氧化氮 (iNO)
- 批准号:
10637303 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
用新型吸入干粉化疗制剂治疗非小细胞肺肿瘤
- 批准号:
10696996 - 财政年份:2023
- 资助金额:
-- - 项目类别:
In vivo tracking of inhaled ACE2 targeting theranostic nanodrugs delivery to the lungs using magnetic particle imaging
使用磁性粒子成像体内跟踪吸入的 ACE2 靶向治疗纳米药物输送到肺部
- 批准号:
10207058 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH
吸入法舒地尔和 DETA NONOate CAR 靶向脂质体治疗 PAH
- 批准号:
10478270 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH
吸入法舒地尔和 DETA NONOate CAR 靶向脂质体治疗 PAH
- 批准号:
10274778 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Develop novel inhaled neutralizing RNA therapeutics against COVID-19
开发针对 COVID-19 的新型吸入中和 RNA 疗法
- 批准号:
10238638 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH
吸入法舒地尔和 DETA NONOate CAR 靶向脂质体治疗 PAH
- 批准号:
9907530 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
用新型吸入干粉化疗制剂治疗非小细胞肺肿瘤
- 批准号:
10080226 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Treating severe asthma in the small airways with a highly efficient and penetrating inhaled dry powder
使用高效、渗透性吸入干粉治疗小气道严重哮喘
- 批准号:
10080247 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Inhaled Delivery of Clofazimine - A High Efficiency, Flow Independent, Targeted, Low Cost DPI
氯法齐明的吸入给药 - 一种高效、不依赖流量、有针对性、低成本的 DPI
- 批准号:
10229327 - 财政年份:2018
- 资助金额:
-- - 项目类别: